| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $15.0M | — |
| R&D Expense | $172.2M | +14.6% |
| SG&A Expense | $50.5M | -0.7% |
| Operating Income | -$207.7M | -3.3% |
| Pre-tax Income | -$195.7M | +16.0% |
| Income Tax | $1.8M | -36.0% |
| Net Income | -$197.5M | +16.2% |
| EPS (Basic) | -$1.46 | +29.1% |
| EPS (Diluted) | -$1.46 | +29.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $61.3M | -84.0% |
| Short-term Investments | $233.3M | +135.7% |
| Current Assets | $367.9M | -31.4% |
| Total Assets | $687.5M | +19.2% |
| Current Liabilities | $42.9M | -26.0% |
| Long-term Debt | $110.1M | +1.1% |
| Total Liabilities | $160.6M | -8.3% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$193.8M | -36.4% |
| Capital Expenditures | $371K | +991.2% |
| Investing Cash Flow | -$418.5M | -1438.6% |
| Financing Cash Flow | $291.5M | -20.1% |
| Free Cash Flow | -$194.2M | -36.7% |
| $526.9M |
| +31.2% |